A Guide To Eye Injections for Macular Degeneration: What to Expect

Eye injections for macular degeneration can slow vision loss and, for many people, even improve sight.

If you or a loved one has been told you need injections, this guide explains what they treat, how they work, the pros and cons of Eylea, what the appointment is like, and how often you may need them.

What do eye injections treat?

Most injections for macular degeneration are designed to treat the “wet” form of age-related macular degeneration (AMD), also called neovascular AMD. In wet AMD, abnormal blood vessels grow under the macula and leak fluid or blood, blurring central vision. Injections help dry up this leakage and stabilize the macula.

These medicines are typically anti-VEGF therapies. VEGF (vascular endothelial growth factor) is a signal that tells new blood vessels to grow; anti-VEGF drugs block that signal. Common options include ranibizumab (Lucentis), aflibercept (Eylea), bevacizumab (Avastin, used off-label), and faricimab (Vabysmo). When effective, they reduce swelling and bleeding, preserve reading and driving vision, and lower the risk of severe vision loss.

While this article focuses on AMD, the same anti-VEGF medicines are also used for other retinal diseases like diabetic macular edema and macular edema from retinal vein occlusion. Dry AMD does not usually require anti-VEGF injections, though newer treatments exist for geographic atrophy; your retina specialist can advise if they’re appropriate for you.

How do the injections work—and what is the procedure like?

The goal is to deliver medicine directly into the eye (the vitreous) where it can act on leaking vessels in the retina. Before the injection, your eye is numbed with anesthetic drops and cleaned with an iodine-based antiseptic to reduce infection risk. A small device may gently hold your eyelids open.

The injection itself takes only a second and is usually felt as brief pressure. You might notice a new floater or a small, harmless red spot on the white of the eye afterward. Most people return to normal activities the same day; your doctor may suggest avoiding eye makeup or contact lenses for 24 hours and will explain any activity restrictions.

Expect your doctor to monitor your progress with vision tests and OCT imaging (a retinal scan) to decide if swelling is improving and whether to adjust the dosing interval.

Eylea (aflibercept): benefits and side effects

Eylea is a widely used anti-VEGF medicine for wet AMD. It binds VEGF (and a related signal, placental growth factor) to stop abnormal vessels from leaking. Many patients respond well to Eylea, with fewer injections needed over time compared with some alternatives. For some, it enables longer intervals between visits once the eye stabilizes.

Benefits can include sharper central vision, improved ability to read and recognize faces, less retinal swelling on OCT, and fewer episodes of bleeding under the retina. In clinical practice, sustained treatment helps many people maintain functional vision for years.

Possible side effects are usually mild and temporary: eye irritation, light sensitivity, floaters, mild eye pain, small surface hemorrhages, and short-term eye pressure increase right after the shot. Serious risks are rare but important: infection inside the eye (endophthalmitis), retinal detachment or tear, cataract from lens touch, and severe inflammation. Signs of infection or detachment include worsening pain, rapidly declining vision, increasing redness, or new flashes and a curtain over vision—seek urgent care if these occur.

Because anti-VEGF drugs enter the bloodstream in tiny amounts, people with recent significant cardiovascular events (like a stroke) should discuss timing and risks with their doctors. Your retina specialist will review your medical history to individualize recommendations.

How often will I need injections?

The frequency depends on your eye’s response and your doctor’s treatment plan. Common schedules include:

Loading phase: Often one injection per month for the first 3 months to quickly control leakage.
Fixed dosing: After loading, many patients receive Eylea every 8 weeks. Some may continue monthly if needed.
Treat-and-extend: If the eye stays dry and vision stable, the interval is gradually extended (for example, 8 to 10 to 12 weeks). If fluid returns, the interval is shortened again. This approach aims to minimize visits while maintaining control.

Your schedule is guided by vision tests and OCT scans rather than a one-size-fits-all calendar. Some eyes require frequent injections long-term; others can stretch visits to 10–12 weeks or longer. Stopping treatment entirely can allow leakage to return, so plan for ongoing maintenance. If one anti-VEGF isn’t working well, your doctor may switch medicines or adjust the strategy.

Costs, coverage, and alternatives

For FDA-approved uses like wet AMD, commercial insurance and Medicare typically cover anti-VEGF injections, though copays and deductibles vary. Manufacturers often provide patient assistance programs. Ask your clinic’s coordinator to check benefits and explore financial support before you start.

Medication options include branded anti-VEGF drugs and, in some settings, bevacizumab compounded for intraocular use at lower cost. Your specialist will consider your eye’s response, safety, convenience, and budget when recommending a plan.

Tips to get the most from treatment

Keep every follow-up, especially in the first 3–6 months when your plan is being fine-tuned.
Report any new distortion, blurriness, or dark spots promptly—early re-treatment prevents setbacks.
Avoid touching or rubbing the eye for the rest of the day after an injection; skip eye makeup and contact lenses for 24 hours unless your doctor says otherwise.
Use any prescribed drops exactly as directed.
Bring a driver for your first visit if you’re unsure how your eyes will feel after dilation.
If you take blood thinners, do not stop them unless your prescribing doctor advises it; a small surface bruise is common and not dangerous.

When to seek urgent care

Severe or worsening eye pain after an injection
Rapid drop in vision, new flashes, or a curtain/veil over vision
Increasing redness with sensitivity to light and discharge
Any sudden, dramatic change in vision between scheduled visits

The bottom line

Eye injections for macular degeneration are a proven way to preserve, and sometimes improve, central vision. With a personalized schedule—often monthly at first, then every 8 to 12 weeks—many people maintain independence in daily tasks. If Eylea is recommended for you, understanding the benefits, potential side effects, and ongoing nature of therapy can help you plan confidently with your retina specialist.